Skip to content

NotablePeer-reviewed

TM184C is a GPCR-like regulator of intercellular exchange and autophagy

ByKyutae David Lee, Sam Taylor, Jennifer Arcuri, Shraddha ChandThakuri, Jacinda Pujols, Bruno Colon and 2 others

University of Miami · Sylvester Comprehensive Cancer Center · Neurological Surgery · Frost Institute for Data Science & Computing

What it is

By mining millions of AlphaFold2 models, the authors identified two human families of 'superdark' seven-transmembrane proteins (TM184 and PRRT) with structural homology to G-protein-coupled receptors (GPCRs), and showed they perform hallmark GPCR activities such as β-arrestin recruitment and GRK-dependent phosphorylation. Focusing on TM184C, the most broadly expressed and conserved of these, they found it localizes to dynamic intracellular vesicles that travel along microtubules and promote tunnelling-nanotube-like intercellular bridges mediating organelle sharing. TM184C also limits autophagic flux by restraining LC3B lipidation and autophagosome accumulation, a role conserved enough that the human protein restores autophagic body homeostasis in yeast lacking its homologue Hfl1.

Why it matters

Most protein annotation depends on sequence similarity, so proteins whose function lies beyond detectable homology stay dark. This work shows that structure-based mining can reach into that dark proteome, assigning a previously obscure protein family GPCR-like behavior and, for TM184C, concrete roles in autophagy, intercellular connectivity, and material exchange.

Underlined numbers link to their source. Every metric and quoted figure is listed under Sources and data below.

Filed underAutophagy in Disease and Therapy, Cellular transport and secretion, Receptor Mechanisms and Signaling

Scored 2026-09-28How scoring works

The Frontier Score, in full

How this entry's score is built, term by term. Open any pillar to see each sub-metric's raw value, how it maps to 0 to 100, and the record that holds it.
Evidence 96Impact 43Novelty 71
The three pillars as one shape: a result strong on every axis fills the triangle.
How the Frontier Score is calculated for this breakthrough
TermScoreWeightPoints
EvidenceHow established and verifiable the result is.96× 0.2523.9
ImpactHow much the result matters, judged field-relative and by current momentum.43× 0.2510.6
NoveltyHow genuinely new the result is, and how fast-moving.71× 0.5035.5
Weighted pillars70.0
Frontier recency1 month since publication× 0.97
IntegrityNot retracted× 1
Frontier Score68
Confidence: Early signal. Early signal: little citation history yet, so impact is an estimate and may shift as the work is taken up.Early signal: little citation history yet, so impact is an estimate and may shift as the work is taken up.

Every sub-metric, traced to its source

Evidence96
Evidence sub-metrics
Sub-metricRaw value0 to 100WeightPointsSource
Peer review & venueWhether the work has cleared peer review, and how selective its venue is. Peer review is necessary but not sufficient: before citations accrue, a fresh result in the most selective venues (Nature, Science, Cell, NEJM, the Lancet, PNAS, Physical Review Letters/X) is a stronger evidence signal than one in a legitimate but very high-volume mega-journal, which in turn outranks a preprint that has not been reviewed at all.Maps to 0 to 100: Peer-reviewed article graded by venue prestige: flagship 100, elite-family 90, high-volume mega-journal 78. Review 90, book 70, dataset 60, preprint 45, other 55.Peer-reviewed1000.3030.0OpenAlex type / primary_location / source
CorroborationIndependent corroboration that the result is real and being taken up, read as the BREADTH of agreement rather than the size of the citation pile. Counts how many of the five independent citation indices (OpenAlex, Crossref, Semantic Scholar, OpenCitations, Europe PMC) report the work at all, plus orthogonal, non-citation lines of corroboration: entry into the encyclopedia, registered clinical trials, released datasets or software, public funding on record, and technical-community discussion. Citation MAGNITUDE is deliberately judged under Impact, not here, so Evidence and Impact measure genuinely different things instead of both rewarding the same citation pile twice.Maps to 0 to 100: Starts at 28 and rises with each of the five independent citation indices that agree the work is cited (+9 each) and each orthogonal non-citation corroboration line (+6 each: Wikipedia, clinical trials, open datasets or software, public funding, community discussion). Capped at 100.5 of 5 citation indices agree, 2 independent non-citation lines850.3025.5OpenAlex, Crossref, Semantic Scholar, OpenCitations, Europe PMC, DataCite, NIH RePORTER, Wikipedia, Hacker News count of agreeing indices + orthogonal reach
VerifiabilityHow openly the result can be read, reused, and reproduced. Rewards open access, a permissive reuse license (CC-BY/CC0), a green repository copy anyone can archive, openly minable full text, and released datasets or software a reader can actually run. Cross-checked across OpenAlex, Unpaywall, Europe PMC, and DataCite.Maps to 0 to 100: Closed 45; open access 80+; a permissive CC license 100; a repository copy, open full text, or a released dataset/software artifact each raise the floor.Open access (hybrid), CC-BY-NC-ND, repository copy1000.2020.0OpenAlex, Unpaywall, Europe PMC, DataCite is_oa / license / has_repository_copy / open datasets
IntegrityRetraction and post-publication correction status. A retracted result is not evidence of anything and collapses the whole Frontier Score; a correction or expression of concern is a softer flag. Read across OpenAlex and Crossref (both update-to and updated-by notices).Maps to 0 to 100: Clean 100; a correction or expression of concern 75; retracted 0. Flagged if OpenAlex OR Crossref records the notice.No retraction or concern on record1000.2020.0OpenAlex, Crossref is_retracted / update-to / updated-by
Impact43
Impact sub-metrics
Sub-metricRaw value0 to 100WeightPointsSource
Field-normalized impactImpact relative to the world average for the same field, year, and type, so a small field and a large field are judged fairly. Triangulates three independent field-normalized measures: OpenAlex's Field-Weighted Citation Impact, its citation percentile within the exact field-and-year cohort, and the NIH iCite Relative Citation Ratio. 1.0x is average; the percentile is the share of same-field, same-year work it out-cites.Maps to 0 to 100: Each ratio (1.0 = field average) maps 1.0 to 50, 3.0 to 75, 9.0 to 90; the field+year percentile maps directly (top 1% -> ~99). The available measures are averaged. Falls back to a saturating citation count when none is available yet.5.1x FWCI, top 4% of field-year vs field900.4540.5OpenAlex, NIH iCite fwci / citation_normalized_percentile / relative_citation_ratio
Influential citationsCitations that genuinely build on the work rather than mention it in passing (Semantic Scholar's influential-citation measure). A sharper signal of real impact than a raw count.Maps to 0 to 100: Saturating: 15 influential citations maps to 50. Falls back to a fraction of consensus citations when unavailable.0 influential00.200.0Semantic Scholar influentialCitationCount
Citation velocityCitations received in the trailing twelve months, judged as a rate rather than a lifetime total. Momentum is what a frontier index cares about: a result being taken up fast right now is landing, whether its lifetime pile is large or still small. Where an expected field citation rate is known, the momentum is also read relative to it, so a fast-moving result in a quiet field is not overlooked.Maps to 0 to 100: Saturating: 30 citations in the last twelve months maps to 50. When NIH iCite provides the field's expected rate, this is blended evenly with the ratio of observed to expected momentum.1 in last 12 months (0.1x field rate)60.352.0OpenAlex, NIH iCite counts_by_year / field_citation_rate
Novelty71
Novelty sub-metrics
Sub-metricRaw value0 to 100WeightPointsSource
Conceptual noveltyHow genuinely new the contribution is, measured at publication from the work's OWN content, not its date: how atypical its combination of research areas is versus all prior work, and whether it builds on a broad, deep base rather than only the newest papers in a fast-moving area. This is what separates a real advance from a recent-but-commodity result, and it needs no forward citations, so it is stable for brand-new work. An honestly noisy proxy (even state-of-the-art novelty measures agree only moderately with expert judgment), so it carries bounded weight and never drives the ranking alone.Maps to 0 to 100: Blends two publication-time signals, each 0-100: an atypical-combination score (how unusual the pairing of the work's research topics is versus the prior literature, by pointwise mutual information) and a foundational-reach score (median age and depth of the work's references). The stronger signal weighs 0.62, the weaker 0.38. When neither is measurable (a work too thin in topics or references), the pillar renormalizes over its recency signals instead.Autophagy in Disease and Therapy x Receptor Mechanisms and Signaling (10 prior works made this pairing); builds on refs a median 10.6y deep550.4524.9OpenAlex topics + referenced_works (publication-time)
RecencyHow recently the work appeared. The frontier is now, so newer scores higher.Maps to 0 to 100: Exponential decay with a 12-month half-life from the publication date.This month970.3029.0OpenAlex publication_date
Attention accelerationWhether attention is rising: citations in the latest full year versus the year before. Accelerating interest signals an active, opening frontier.Maps to 0 to 100: Latest/prior-year ratio: 1x maps to 50, 2x to 75, 4x to 100. Unknown is neutral.Not enough history500.105.0OpenAlex counts_by_year
Edge of reviewPreprints and brand-new work sit ahead of the peer-review process. That earns novelty here (while it is discounted under Evidence), because it is where the frontier forms first.Maps to 0 to 100: Preprint 95, article <6 months 80, article <18 months 65, else 45.Peer-reviewed record800.1512.0OpenAlex type / publication_date
ProvenanceAll sources

Sources and data

Every number behind this entry, grouped by the source that holds it: up to five citation indices cross-checked, field-normalized impact, then real-world reach (Wikipedia, community discussion, clinical trials, released data and public funding) where it exists. Each value links to its record.

OpenAlex

Primary record
Total citations
1
Field-weighted citation impact
5.1x field average
Citation percentile
Top 4% of its field-year
Citations, recent 12 months
1
Publication date
2026-09-09

Crossref

Citations
1
Works it builds on
55

Semantic Scholar

Citations, all versions
1
Influential citations
0

OpenCitations

Citations
0

Europe PMC

Citations
1

NIH iCite

Potential to translate
5%

Unpaywall

Reuse license
CC-BY-NC-ND

NIH RePORTER

NIH grants funding it
1
NIH award funding
$4,121,879

Figures quoted in the write-up

FigureValueSource
AlphaFold2 models mined (Structural mining used to find superdark seven-transmembrane proteins)millionsNature
Superdark 7TM families (TM184 and PRRT, both with GPCR structural homology)twoNature
Biomedicine & HealthThe whole field

Back to the Frontier Index, or browse every breakthrough by date.

The Frontier Brief

The week's frontier, scored.

Every Monday, the highest-scoring new breakthroughs in the index, each with its score and a one-line read on why it matters. What you get

One email a week. The top new breakthroughs, scored. Unsubscribe anytime.